摘要
目的观察膀胱癌术后灌注化疗防治膀胱癌术后复发的疗效。方法A组患者用丝裂霉素C40mg溶于无菌生理盐水40ml,膀胱内灌注,每周1次,共6次,再序联用BCG 150mg加IL-21.0×10^5 U溶于无菌生理盐水40ml,膀胱内灌注,每周1次,共6次,此后用BCG 150mg加IL-21.0×10^5U溶于无菌生理盐水40ml,膀胱内灌注,每月1次,共2年。B组患者用丝裂霉素C40mg溶于无菌牛理盐水40ml,膀胱内灌注,每周1次,共6次,改为每月灌注1次,共2年。结果随访24~30个月,A组平均27个月,有效率93.3%B组平均28个月,有效率43.2%。结论MMC序联BCG加IL-2膀胱内灌注较单用MMC更有效地防治膀胱癌术后复发。
Objective To observe the effects of infusion chemotherapy for preventing bladder cancer recurrence after operation. Methods 67 cases were divided into two groups. The patients in group A used MMC 40mg dissolved in sterile saline 40ml that were infused in bladder once a week, after six times, combined with BCG 150mg plus IL - 2 1.0 × 105u. All these medicines were dissolved in sterile saline 40ml that were irrigated in the bladder once a month, for a total of two years. The patients in group B with MMC 40mg dissolved in sterile saline 40ml that were infused once a week, a total of six weeks, the re - in- fusion once a month, for a total of two years. Results 24 - 30 months in follow up, an average of 27 months in group A, the ef- fective rate is 93.3% , the group B effective rate is 43.3% , on average 28 months. Conclusion MMC combine with BCG and IL -2 infused in bladder were much more effective than MMC alone to prevent bladder cancer recurrence.
出处
《安徽医学》
2008年第3期278-280,共3页
Anhui Medical Journal